ANDA Suitability for Carbidopa/Levodopa Powder for Reconstitution to an Oral Liquid | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-1995-P-0005

ANDA Suitability for Carbidopa/Levodopa Powder for Reconstitution to an Oral Liquid

Documents

Comments

Description

Docket Status: CLOSED

Comment Period OpensApr 17, 1995

Comment Period ClosesMar 27, 2007

Type	Title	Posted	Comments	Status
Supporting Material	Appendix A Bayer et al Bioavailability and Acceptability of a Dispersible Formulation of Levodopa-Benserazide in Parkinsonian Patients with and without Dysphagia Journal of Clinical Pharmacy and Therapeutics (1988) 13, 191-194. re: Comment from Dupont Merck	Mar 31, 2017

Total Comments

LEVODOPA

RECONSTITUTION

ORAL LIQUID

POWDER

CARBIDOPA

CLOSED

CITIZEN PETITION

CDER

ATHENA NEUROSCIENCES, INC